Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Arcturus Therapeutics Holdings Inc. (ARCT)

Arcturus Q3 net loss narrows to $7.4 million; nine-month loss widens to $58.2 million

Mixed Impact 3 of 5 earnings Written later

Arcturus reported results for the quarter ended September 30, 2026. Third-quarter revenue rose to $18.3 million and the net loss narrowed to $7.4 million, helped by a $12.0 million termination payment from CSL Seqirus. For the nine months, revenue fell to $23.3 million from $74.8 million and the net loss widened to $58.2 million, and cash and cash equivalents declined to $184.8 million from $230.9 million at year-end 2025.

Key points

  • Q3 2026 revenue was $18.3 million, up from $17.2 million a year earlier, mainly from recognizing the $12.0 million CSL Seqirus termination payment and remaining deferred revenue.
  • Q3 2026 net loss was $7.4 million, or $0.26 per share, compared with $13.4 million, or $0.49 per share, in Q3 2025.
  • Nine-month 2026 revenue was $23.3 million versus $74.8 million, and the nine-month net loss was $58.2 million, or $2.05 per share, versus $36.7 million, or $1.35 per share.
  • Cash and cash equivalents were $184.8 million at September 30, 2026; the company said cash runway extends through year-end 2028.

The filing

CompanyArcturus Therapeutics Holdings Inc. (ARCT)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:06 PM ET
Accession number0001193805-26-001439

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.